Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. - Wikidata - awgldk - TriplyDB

Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial.

Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial.

http://www.wikidata.org/entity/Q36720273

about

The artificial pancreas: is it important to understand how the β cell controls blood glucose?A Review of Safety and Design Requirements of the Artificial Pancreas.Heart rate informed artificial pancreas system enhances glycemic control during exercise in adolescents with T1D.Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus.Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp.Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes Closed-loop artificial pancreas systems: physiological input to enhance next-generation devices.Evaluation of stochastic adjustment for glucose sensor bias during closed-loop insulin delivery Algorithms for a closed-loop artificial pancreas: the case for model predictive control.Dexcom G4AP: an advanced continuous glucose monitor for the artificial pancreas.Feasibility study of a bio-inspired artificial pancreas in adults with type 1 diabetes.A closed-loop artificial pancreas using a proportional integral derivative with double phase lead controller based on a new nonlinear model of glucose metabolism The artificial pancreas: current status and future prospects in the management of diabetes.Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol.Outpatient glycemic control with a bionic pancreas in type 1 diabetes.Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trial Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals.Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery.Evaluating the Performance of a Novel Embedded Closed-loop System.An integrated multivariable artificial pancreas control system Preliminary evaluation of a new semi-closed-loop insulin therapy system over the prandial period in adult patients with type 1 diabetes: the WP6.0 Diabeloop study Classification of Physical Activity: Information to Artificial Pancreas Control Systems in Real Time.Meal Detection in Patients With Type 1 Diabetes: A New Module for the Multivariable Adaptive Artificial Pancreas Control System Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial Periodic-zone model predictive control for diurnal closed-loop operation of an artificial pancreas.Evaluation of a minimally invasive glucose biosensor for continuous tissue monitoring.Artificial pancreas using a personalized rule-based controller achieves overnight normoglycemia in patients with type 1 diabetes.Closed-loop artificial pancreas systems: engineering the algorithms.Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial.Use of Wearable Sensors and Biometric Variables in an Artificial Pancreas System.Glucose control in non-critically ill inpatients with diabetes: towards closed-loop.Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems.Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3-6 years: comparison between diluted and standard insulin strength.Model-Free Machine Learning in Biomedicine: Feasibility Study in Type 1 Diabetes.Exercise, hypoglycemia, and type 1 diabetes.Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial.Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial.

P2860

Q26852992-1E44D880-5E0F-44DD-A3EB-7A63898CC8A2 Q28066687-877B9939-9D5C-41F7-9B5E-668412428BCF Q30275746-52EEF439-4D5F-47F0-BDD2-8B0254ABC550 Q30300933-BDEFC4D2-5916-43AF-A621-65A7B4E97F7F Q30301357-FF464D9E-A0DD-471A-B62F-0ED692B6AB80 Q30370613-9B5C21E0-F11D-486D-B1D2-B49EBAB43555 Q30371580-ED207680-D889-4B30-B043-10BDDF2F1819 Q30371583-43449DB6-74C5-45F6-BF70-109285DDF4CD Q30405467-5A2DB740-80F6-4D05-B04F-B0257B5258B1 Q30407675-0F96D9ED-05B9-455D-A782-242B4D47CD91 Q30409797-AE8943BB-F48E-4C15-9EB8-7BAC6D289BDF Q30409815-E19901BF-B9AD-46C3-92B6-1E88782F9EAA Q30410965-2ED1C5F7-FFFA-4AC5-8086-61D6110769FB Q30413389-731AC591-5F95-469F-8B9D-8A8052BA7C7C Q33440813-70D56C88-75A0-4AF4-B84B-278496A7F16A Q33569031-F4B00150-6FB2-40BF-946E-DE04113FA1FB Q34151693-D2794323-4A4A-457A-9C76-E7BE2CD82B1F Q34283269-B24C0A0F-6F80-4D86-A523-7B4B3FE0CAE4 Q34315968-9F665A7A-3970-4D52-B51B-53A28BEE114C Q34360613-5B86A0CB-9F42-474D-83F5-1943F5B10CE1 Q35176744-7525109D-2ADF-461A-85F5-4992FACE31AE Q35682761-8BF7B0E4-C527-4853-A6A6-6DCD934EF217 Q35682836-104CA5F2-F6E0-4313-A580-55E8A8F9B5E5 Q35682897-17AC5E9D-B35F-41EC-BCAA-DE0F00CE1296 Q36340401-DF06142B-B36C-40C2-8250-D2AFA3D1F8A4 Q36463327-A5EC5D38-A08C-4076-93C4-B2186F58B792 Q36800053-DC2E0198-F50A-4BBE-92C3-5FA41A1ED4A9 Q37421555-8CD4583F-1FA6-4C0A-9F94-EFFC0D57FA8B Q37424166-BFE23B65-2DD7-42ED-BBD9-3E1502C00780 Q37602679-4ECB7514-C25C-439F-A134-316330E5FE82 Q37715545-DE9974D1-A683-4842-BFA5-C84FE511121F Q37715553-E04D897D-B77A-4B39-A703-A5D8ED882C96 Q37732630-A7D2B3EB-F7E1-4A17-ADDD-3BD55F0E1FFB Q38165285-E7A4C37E-2DCD-4E91-A982-4A4433F4ECE1 Q38205861-638E064C-A869-499D-8FAB-4CE27FBF8804 Q38419059-DCEE5AED-4F68-4648-9DAD-F9A00E1C4DF4 Q42408972-045C3B06-4444-4F34-A7F8-41C5DDEB04EC Q42583058-31F1FAB2-CDE0-4B65-9A8C-F6F1F9F030B0 Q42718199-AD5940AB-FC2A-421E-B3E1-1EFC51D0016E Q47288459-1703579F-F20B-45DC-A291-7F06F15CA723

P2860

Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial.

http://www.wikidata.org/entity/Q36720273

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Closed-loop basal insulin deli ...... es: randomized clinical trial.

@ast

Closed-loop basal insulin deli ...... es: randomized clinical trial.

@en

type

label

Closed-loop basal insulin deli ...... es: randomized clinical trial.

@ast

Closed-loop basal insulin deli ...... es: randomized clinical trial.

@en

prefLabel

Closed-loop basal insulin deli ...... es: randomized clinical trial.

@ast

Closed-loop basal insulin deli ...... es: randomized clinical trial.

@en

P1433

Q36720273-39915C4E-0259-404F-B931-C7195DFDAA5D

P1476

Q36720273-A6DB6961-894E-4097-88AC-40A9A7A70BD0

P2093

Q36720273-10B2D327-0664-45F1-88C0-C06A209BBB34

Q36720273-7FAF3BBA-3943-4D5C-99BD-C2F6AC07135C

Q36720273-85A680BC-4490-4C72-8530-E02F59AB4392

Q36720273-9E624E6E-03FA-417F-833A-5E4188ABD403

Q36720273-B2ED2488-9988-4F55-8716-BF27368BB215

Q36720273-BC3A9D9E-84BE-4FE1-8CC0-A1F03D0374F5

Q36720273-BEC15BAA-147B-473E-910D-4F704492E160

Q36720273-ECCA5B8C-57A1-4A0D-B852-C95078A96C79

Q36720273-F484D1EF-8A9B-4152-8332-0D0D4373F0E2

P2860

Q36720273-034CBF39-9899-4964-9FEC-308E6E61B889

Q36720273-0ABABF37-D1C2-4977-B265-1A2C60BDCF89

Q36720273-146D972A-D562-4C5A-ABA9-153B30068EFC

Q36720273-16F97089-B616-4BB3-A482-E3A8E7F6385C

Q36720273-180D4D36-83A1-4923-92BA-ADBB1455D5DD

Q36720273-2FC3020B-E748-4171-BBD3-14117ED5630B

Q36720273-3C054C82-445D-4E38-A661-EFAB6C9CFE19

Q36720273-3CCF0BF7-1189-4881-8E2A-BBBEAEAA7308

Q36720273-4C998D7D-5308-41C1-98BE-2DA0116897C0

Q36720273-5AB62F86-E901-4049-AAA7-F487CA044103

P304

Q36720273-9A4FE178-624B-4C63-B1B7-958BE2C65490

P31

Q36720273-4E8B1AEE-D16B-42D7-A2C4-469CD81B2284

P356

Q36720273-0FE210F9-AE09-44E2-9F59-3DEE249383F3

P407

Q36720273-D9EFE782-FDFD-4B41-8102-EF0FBEB271D5

P433

Q36720273-410EF4E4-E41E-4096-AA60-9BA1BA2FF18C

P478

Q36720273-1C27F7C1-4D2F-4231-8181-2E1B3538AA15

P50

Q36720273-256574C7-AE0C-46BB-8A6C-3EC7C47927E7

Q36720273-48DBC07F-0A89-4ED0-9EEF-55FD22B0111E

Q36720273-9EBD53EE-6DA2-4CC1-855D-B4B3427682D9

Q36720273-A211BD1B-9634-446F-A1DF-53031F062CF9

Q36720273-E513AF8E-620D-463A-9F7B-E6AB74A126AE

P577

Q36720273-3A997057-31B3-4176-B58B-4D6183E45EC0

P5875

Q36720273-6D89B345-1735-481E-BC65-4FA623D951B9

P698

Q36720273-9468B7BB-1922-42C6-B686-0195E503DE47

P921

Q36720273-08D0FA89-1DE3-4533-BD6E-D20F469D365E

Q36720273-2B8F0B1A-3DA9-4581-8DC4-A3D6B3203EC6

Q36720273-C145AA55-AD81-4C78-ABAA-E6FEA8FB57B8

P932

Q36720273-1E8E20C6-B2A6-4E8A-9CEB-971ACDB1C3FA

P356

P1433

P1476

Closed-loop basal insulin deli ...... es: randomized clinical trial.

@en

P2093

Ahmad Haidar

http://www.w3.org/2001/XMLSchema#string

Daniela Elleri

http://www.w3.org/2001/XMLSchema#string

Helen R Murphy

http://www.w3.org/2001/XMLSchema#string

Janet M Allen

http://www.w3.org/2001/XMLSchema#string

Karen Caldwell

http://www.w3.org/2001/XMLSchema#string

Kavita Kumareswaran

http://www.w3.org/2001/XMLSchema#string

Malgorzata E Wilinska

http://www.w3.org/2001/XMLSchema#string

Marianna Nodale

http://www.w3.org/2001/XMLSchema#string

Peiyao Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies

Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes.

The original Clarke Error Grid Analysis (EGA).

Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index.

Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial

Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes

Factors influencing the effectiveness of glucagon for preventing hypoglycemia.

Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes.

Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.

A bihormonal closed-loop artificial pancreas for type 1 diabetes

P304

838-844

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC12-0816

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

David B. Dunger

Lalantha Leelarathna

Carlo L Acerini

P577

2012-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233799000

http://www.w3.org/2001/XMLSchema#string

P698

23193217

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3609499

http://www.w3.org/2001/XMLSchema#string